Timing of assessments
| Randomisation (visit 1) | 1/3 have 2 TCS (visit 2) | Follow-up 1 | Follow-up 2 | |
| Time since stroke | 6–12 weeks | 6 weeks after randomisation | 6 months | 12 months |
| Clinical examination and risk factors* | X | X | X | |
| Current medications | X | X | X | |
| Medication adherence | X | |||
| Rehabilitation, support, work information | X | X | X | X |
| SF-36v2 | X | |||
| SF-12v2 | X | X | X | |
| mRS, BI, FAI, PHQ-2, EuroQOL EQ-5D, PAM, CSI | X | X | X | X |
*Includes heart rate, heart rhythm, blood pressure, height and weight, smoking status, diabetes, anticoagulation status.
BI, Barthel Index; CSI, Caregiver Strain Index; EQ-5D, euroQol Five-Dimensional scores; FAI, Frenchay Activities Index; mRS, modified Rankin scale; PAM, Patient Activation Measure; PHQ-2, Patient Health Questionnaire-2; SF-12v2, Short-Form 12 version 2; SF-36v2, Short-Form 36 version 2; TCS, Take Charge Session.